| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 22.83M | — |
| Operating expense | — | — |
| Net income | -6.20M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NPCE returned +56.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -9.1% |
| 1 year | +56.1% |
| 5 years | -33.9% |
| All-time high | $24.16 (Apr 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NPCE would be worth today ›No. NeuroPace, Inc. has not paid a dividend in the past 12 months.
NeuroPace, Inc. stock trades on NASDAQ under the ticker symbol NPCE.
NeuroPace, Inc. is part of the Healthcare sector.
NeuroPace, Inc. has a market cap of 481.57M USD, based on the latest quote.
NeuroPace, Inc. is scheduled to report earnings on Nov 3, 2026.
